Stay updated with breaking news from Nyse Zyme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target […]
Zymeworks (NYSE:ZYME – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Thursday, August 10th. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Zymeworks (NYSE:ZYME – […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price […]
Zymeworks Inc. (NYSE:ZYME – Get Rating) major shareholder Ecor1 Capital, Llc bought 3,350,000 shares of the stock in a transaction dated Friday, June 16th. The stock was bought at an average price of $8.12 per share, with a total value of $27,202,000.00. Following the purchase, the insider now owns 13,437,473 shares of the company’s stock, […]